Methanandamide
This is an old revision of this page, as edited by Monkbot (talk | contribs) at 18:01, 1 September 2015 (Task 7c: repair/replace et al. in cs1 author/editor parameters;). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.
Names | |
---|---|
IUPAC name
(5Z,8Z,11Z,14Z)-N-[(1R)-2-hydroxy-1-methylethyl]icosa-5,8,11,14-tetraenamide
| |
Other names
AM-356; Arachidonyl-1'-hydroxy-2'-propylamide
| |
Identifiers | |
3D model (JSmol)
|
|
ChEMBL | |
ChemSpider |
|
PubChem CID
|
|
| |
| |
Properties | |
C23H39NO2 | |
Molar mass | 361.570 g·mol−1 |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|
Methanandamide (AM-356) is a synthetically created stable chiral analog of anandamide.[1] Its effects have been observed to act on the cannabinoid receptors (specifically on CB1 receptors, which are part of the central nervous system) found in different organisms such as mammals, fish, and certain invertebrates (e.g. Hydra).
References
- ^ Abadji, V; et al. (1994). "(R)-methanandamide: A chiral novel anandamide possessing higher potency and metabolic stability". Journal of Medical Chemistry. 37 (12): 1889–93. doi:10.1021/jm00038a020. PMID 8021930.
Receptor (ligands) |
| ||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Transporter (modulators) |
| ||||||||||||||||||||||||||||||
Enzyme (modulators) |
| ||||||||||||||||||||||||||||||
Others |
| ||||||||||||||||||||||||||||||
|
This cannabinoid related article is a stub. You can help Wikipedia by expanding it. |
This biochemistry article is a stub. You can help Wikipedia by expanding it. |